The Biotechnology & Pharmaceutical industry is nearly as broad and vast as the diseases and conditions it aims to alleviate. The team at Panitch Schwarze has deep knowledge of the Biotechnology & Pharmaceutical industries, including the specific areas of:
- Small Molecule Pharmaceuticals
- Large Molecules, Biologics & Antibody Therapeutics
- Vaccine Development & Delivery
- Systems & Methods for Targeted Delivery of Pharmaceuticals
Pharmaceuticals, whether small molecule organic compounds or large molecule biologic compounds, such as proteins and antibodies, are critical in preserving health, curing disease, and alleviating symptoms in people and are essential for modern society. New pharmaceuticals must be continuously developed to treat previously intractable diseases, newly emerged diseases, and supplement or replace previous drugs that are no longer effective, e.g., because of developed antibiotic resistance.
In addition, to alleviating disease through novel pharmaceuticals, it is critical to continue to develop novel vaccines to prevent diseases. The need for continued vaccine development has been highlighted particularly well during the COVID-19 pandemic.
Along with new pharmaceuticals and vaccines, the development of formulations and drug delivery systems to effectively transport biologic and small molecule compounds to target areas in the body is essential for efficacy and to minimize toxic side effects.
The team at Panitch Schwarze has deep knowledge of the pharmaceutical and biotechnology industries, helping clients safeguard, monetize, and enforce their intellectual property. We are experienced in preparing patent applications within the Biotechnology & Pharmaceutical industry, prosecuting them before the U.S. Patent & Trademark Office and, with our extensive network of foreign law firms, securing granted patents internationally. We manage complex international portfolios for our clients, providing counsel on maintaining and extending patent protection, e.g., through obtaining Patent Term Extension (PTE) and Supplementary Protection Certificates (SPCs) to compensate for delays in bringing a drug to market associated with the regulatory approval process. We conduct freedom to operate, patentability, and due diligence analyses to assist our clients in making decisions on collaborations and research and development on new products. We assist with negotiating and drafting numerous types of agreements that are critical to the industry, including joint research agreements and in- and out-licenses, and we assist clients with challenges to the IP rights of others and the enforcement of the valuable IP rights they have secured through contested proceedings at the Patent Trial and Appeal Board and federal courts. We integrate consideration of commercial, regulatory approval, scientific, and patent legal factors in developing and implementing successful IP strategies to attain the goals of our clients.
To learn more about how Panitch Schwarze intellectual property lawyers can help you, please contact us.